
2.50 Delayed Data As of Mar 23 | ![]() Today’s Change | 1.41 Today|||52-Week Range 3.40 | +34.41% Year-to-Date |
The 2 analysts offering 12-month price forecasts for Ovid Therapeutics Inc have a median target of 4.75, with a high estimate of 7.00 and a low estimate of 2.50. The median estimate represents a +90.00% increase from the last price of 2.50.
The current consensus among 4 polled investment analysts is to Buy stock in Ovid Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.